Skip to main content
Erschienen in: Inflammation 2/2022

03.02.2022 | Original Article

Upregulation of Unfolded Protein Response and ER Stress–Related IL-23 Production in M1 Macrophages from Ankylosing Spondylitis Patients

verfasst von: Alireza Rezaiemanesh, Mahdi Mahmoudi, Ali Akbar Amirzargar, Mahdi Vojdanian, Farhad Babaie, Jila Mahdavi, Misagh Rajabinejad, Ahmad Reza Jamshidi, Mohammad Hossein Nicknam

Erschienen in: Inflammation | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

The inflammatory interleukin (IL)-23/IL-17 axis plays an important role in the pathogenesis of ankylosing spondylitis (AS), but with an unknown regulatory mechanism. This study aimed to investigate the role of endoplasmic reticulum (ER) stress and autophagy pathway in the expression of IL-23 in peripheral blood–derived macrophages in AS patients. Peripheral blood samples were obtained from 15 AS and 15 healthy control subjects. MACS was used to isolate monocytes from PBMCs. Then, M-CSF was used to differentiate monocytes to M2 macrophages. IFN-γ and/or LPS were used to activate macrophages and M2 polarization towards M1 macrophages. Thapsigargin was used to induce ER stress and 3-MA to inhibit autophagy. The purity of extracted monocytes and macrophage markers was evaluated by flow cytometry. mRNA expression of HLA-B and-B27, ER stress–related genes, autophagy-related genes, and IL-23p19 was performed using RT-qPCR. Soluble levels of IL-23p19 were measured using ELISA. Significant increase in mRNA expression of HLA-B, HLA-B27, BiP, XBP1, CHOP, and PERK mRNAs was observed in macrophages of AS patients before and after stimulation with IFN-γ and LPS. No significant change in autophagy gene expression was detected. mRNA and soluble levels of IL-23p19 demonstrated a significant increase in macrophages of AS patients compared to healthy subjects. ER stress induction led to a significant increase in IL-23p19 in macrophages. Inhibition of autophagy did not affect IL-23 expression. ER stress, unlike autophagy, is associated with increased IL-23 levels in macrophages of AS patients.
Key Messages
  • ER stress in macrophages from AS patients plays a role in the increased production of IL-23.
  • The autophagy pathway is not involved in the modulation of IL-23 production by AS macrophages.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ranganathan, V., E. Gracey, M.A. Brown, R.D. Inman, and N. Haroon. 2017. Pathogenesis of ankylosing spondylitis—recent advances and future directions. Nature Reviews Rheumatology 13: 359.CrossRef Ranganathan, V., E. Gracey, M.A. Brown, R.D. Inman, and N. Haroon. 2017. Pathogenesis of ankylosing spondylitis—recent advances and future directions. Nature Reviews Rheumatology 13: 359.CrossRef
2.
Zurück zum Zitat Mahmoudi, M., S. Aslani, M.H. Nicknam, J. Karami, and A.R. Jamshidi. 2017. New insights toward the pathogenesis of ankylosing spondylitis; genetic variations and epigenetic modifications. Modern rheumatology 27: 198–209.CrossRef Mahmoudi, M., S. Aslani, M.H. Nicknam, J. Karami, and A.R. Jamshidi. 2017. New insights toward the pathogenesis of ankylosing spondylitis; genetic variations and epigenetic modifications. Modern rheumatology 27: 198–209.CrossRef
3.
Zurück zum Zitat Mohammadi H, F., Babaie, M., Hemmatzadeh, G., Azizi, M., Hajaliloo, A. A., Ebrahimi, T., Kazemi, M., Yousefi, A., Rezaiemanesh, E., afarzadeh, E., Baghbani. 2018 Oct 20. Evaluation of ERAP1 gene single nucleotide polymorphism in impressing the inflammatory cytokine profile of ankylosing spondylitis patients. Iranian Journal of Allergy, Asthma and Immunology 464–474. Mohammadi H, F., Babaie, M., Hemmatzadeh, G., Azizi, M., Hajaliloo, A. A., Ebrahimi, T., Kazemi, M., Yousefi, A., Rezaiemanesh, E., afarzadeh, E., Baghbani. 2018 Oct 20. Evaluation of ERAP1 gene single nucleotide polymorphism in impressing the inflammatory cytokine profile of ankylosing spondylitis patients. Iranian Journal of Allergy, Asthma and Immunology 464–474.
4.
Zurück zum Zitat García-Medel, N., A. Sanz-Bravo, C. Alvarez-Navarro, P. Gómez-Molina, E. Barnea, M. Marcilla, A. Admon, and J.A.L. de Castro. 2014. Peptide handling by HLA-B27 subtypes influences their biological behavior association with ankylosing spondylitis and susceptibility to endoplasmic reticulum aminopeptidase 1 (ERAP1). Molecular & Cellular Proteomics 13: 3367–3380.CrossRef García-Medel, N., A. Sanz-Bravo, C. Alvarez-Navarro, P. Gómez-Molina, E. Barnea, M. Marcilla, A. Admon, and J.A.L. de Castro. 2014. Peptide handling by HLA-B27 subtypes influences their biological behavior association with ankylosing spondylitis and susceptibility to endoplasmic reticulum aminopeptidase 1 (ERAP1). Molecular & Cellular Proteomics 13: 3367–3380.CrossRef
5.
Zurück zum Zitat Dashti, N., M. Mahmoudi, S. Aslani, and A. Jamshidi. 2018. HLA-B* 27 subtypes and their implications in the pathogenesis of ankylosing spondylitis. Gene 670: 15–21.CrossRef Dashti, N., M. Mahmoudi, S. Aslani, and A. Jamshidi. 2018. HLA-B* 27 subtypes and their implications in the pathogenesis of ankylosing spondylitis. Gene 670: 15–21.CrossRef
6.
Zurück zum Zitat Schittenhelm, R.B., T.C.L.K. Sian, P.G. Wilmann, N.L. Dudek, and A.W. Purcell. 2015. Revisiting the arthritogenic peptide theory: Quantitative not qualitative changes in the peptide repertoire of HLA–B27 allotypes. Arthritis & rheumatology 67: 702–713.CrossRef Schittenhelm, R.B., T.C.L.K. Sian, P.G. Wilmann, N.L. Dudek, and A.W. Purcell. 2015. Revisiting the arthritogenic peptide theory: Quantitative not qualitative changes in the peptide repertoire of HLA–B27 allotypes. Arthritis & rheumatology 67: 702–713.CrossRef
7.
Zurück zum Zitat Rysnik, O., K. McHugh, L. van Duivenvoorde, M. van Tok, G. Guggino, J. Taurog, S. Kollnberger, F. Ciccia, D. Baeten, and P. Bowness. 2016. Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue. Journal of autoimmunity 70: 12–21.CrossRef Rysnik, O., K. McHugh, L. van Duivenvoorde, M. van Tok, G. Guggino, J. Taurog, S. Kollnberger, F. Ciccia, D. Baeten, and P. Bowness. 2016. Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue. Journal of autoimmunity 70: 12–21.CrossRef
8.
Zurück zum Zitat Colbert, R.A., M.L. DeLay, E.I. Klenk, and G. Layh-Schmitt. 2010. From HLA-B27 to spondyloarthritis: A journey through the ER. Immunological reviews 233: 181–202.CrossRef Colbert, R.A., M.L. DeLay, E.I. Klenk, and G. Layh-Schmitt. 2010. From HLA-B27 to spondyloarthritis: A journey through the ER. Immunological reviews 233: 181–202.CrossRef
9.
Zurück zum Zitat Bowness, P., A. Ridley, J. Shaw, A.T. Chan, I. Wong-Baeza, M. Fleming, F. Cummings, A. McMichael, and S. Kollnberger. 2011. Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis. The Journal of Immunology 186: 2672–2680.CrossRef Bowness, P., A. Ridley, J. Shaw, A.T. Chan, I. Wong-Baeza, M. Fleming, F. Cummings, A. McMichael, and S. Kollnberger. 2011. Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis. The Journal of Immunology 186: 2672–2680.CrossRef
10.
Zurück zum Zitat Babaie, F., M. Hasankhani, H. Mohammadi, E. Safarzadeh, A. Rezaiemanesh, R. Salimi, B. Baradaran, and Z. Babaloo. 2018. The role of gut microbiota and IL-23/IL-17 pathway in ankylosing spondylitis immunopathogenesis: New insights and updates. Immunology letters 196: 52–62.CrossRef Babaie, F., M. Hasankhani, H. Mohammadi, E. Safarzadeh, A. Rezaiemanesh, R. Salimi, B. Baradaran, and Z. Babaloo. 2018. The role of gut microbiota and IL-23/IL-17 pathway in ankylosing spondylitis immunopathogenesis: New insights and updates. Immunology letters 196: 52–62.CrossRef
11.
Zurück zum Zitat Rezaiemanesh, A., M. Abdolmaleki, K. Abdolmohammadi, H. Aghaei, F.D. Pakdel, Y. Fatahi, N. Soleimanifar, M. Zavvar, and M.H. Nicknam. 2018. Immune cells involved in the pathogenesis of ankylosing spondylitis. Biomedicine & Pharmacotherapy 100: 198–204.CrossRef Rezaiemanesh, A., M. Abdolmaleki, K. Abdolmohammadi, H. Aghaei, F.D. Pakdel, Y. Fatahi, N. Soleimanifar, M. Zavvar, and M.H. Nicknam. 2018. Immune cells involved in the pathogenesis of ankylosing spondylitis. Biomedicine & Pharmacotherapy 100: 198–204.CrossRef
12.
Zurück zum Zitat Ridley, A., H. Hatano, I. Wong-Baeza, J. Shaw, K.K. Matthews, H. Al-Mossawi, K. Ladell, D.A. Price, P. Bowness, and S. Kollnberger. 2016. Activation-induced killer cell immunoglobulin-like receptor 3DL2 binding to HLA–B27 licenses pathogenic t cell differentiation in spondyloarthritis. Arthritis & rheumatology 68: 901–914.CrossRef Ridley, A., H. Hatano, I. Wong-Baeza, J. Shaw, K.K. Matthews, H. Al-Mossawi, K. Ladell, D.A. Price, P. Bowness, and S. Kollnberger. 2016. Activation-induced killer cell immunoglobulin-like receptor 3DL2 binding to HLA–B27 licenses pathogenic t cell differentiation in spondyloarthritis. Arthritis & rheumatology 68: 901–914.CrossRef
13.
Zurück zum Zitat Ciccia, F., and N. Haroon. 2016. Autophagy in the pathogenesis of ankylosing spondylitis. Clinical rheumatology 35: 1433–1436.CrossRef Ciccia, F., and N. Haroon. 2016. Autophagy in the pathogenesis of ankylosing spondylitis. Clinical rheumatology 35: 1433–1436.CrossRef
14.
Zurück zum Zitat Neerinckx, B., S. Carter, and R. . 2014. Lories. IL-23 expression and activation of autophagy in synovium and PBMCs of HLA-B27 positive patients with ankylosing spondylitis. Arthritis & Rheumatology 66: S844–S844. Neerinckx, B., S. Carter, and R. . 2014. Lories. IL-23 expression and activation of autophagy in synovium and PBMCs of HLA-B27 positive patients with ankylosing spondylitis. Arthritis & Rheumatology 66: S844–S844.
15.
Zurück zum Zitat Rezaiemanesh, A., M. Mahmoudi, A.A. Amirzargar, M. Vojdanian, A.R. Jamshidi, and M.H. Nicknam. 2017. Ankylosing spondylitis M-CSF-derived macrophages are undergoing unfolded protein response (UPR) and express higher levels of interleukin-23. Modern rheumatology 27: 862–867.CrossRef Rezaiemanesh, A., M. Mahmoudi, A.A. Amirzargar, M. Vojdanian, A.R. Jamshidi, and M.H. Nicknam. 2017. Ankylosing spondylitis M-CSF-derived macrophages are undergoing unfolded protein response (UPR) and express higher levels of interleukin-23. Modern rheumatology 27: 862–867.CrossRef
16.
Zurück zum Zitat Zeng, L., M.J. Lindstrom, and J.A. Smith. 2011. Ankylosing spondylitis macrophage production of higher levels of interleukin-23 in response to lipopolysaccharide without induction of a significant unfolded protein response. Arthritis & Rheumatism 63: 3807–3817.CrossRef Zeng, L., M.J. Lindstrom, and J.A. Smith. 2011. Ankylosing spondylitis macrophage production of higher levels of interleukin-23 in response to lipopolysaccharide without induction of a significant unfolded protein response. Arthritis & Rheumatism 63: 3807–3817.CrossRef
17.
Zurück zum Zitat Svensson, J., M.C. Jenmalm, A. Matussek, R. Geffers, G. Berg, and J. Ernerudh. 2011. Macrophages at the fetal–maternal interface express markers of alternative activation and are induced by M-CSF and IL-10. The Journal of Immunology 187: 3671–3682.CrossRef Svensson, J., M.C. Jenmalm, A. Matussek, R. Geffers, G. Berg, and J. Ernerudh. 2011. Macrophages at the fetal–maternal interface express markers of alternative activation and are induced by M-CSF and IL-10. The Journal of Immunology 187: 3671–3682.CrossRef
18.
Zurück zum Zitat Brown, M.B., M. von Chamier, A.B. Allam, and L. Reyes. 2014. M1/M2 macrophage polarity in normal and complicated pregnancy. Frontiers in immunology 5: 606.PubMedPubMedCentral Brown, M.B., M. von Chamier, A.B. Allam, and L. Reyes. 2014. M1/M2 macrophage polarity in normal and complicated pregnancy. Frontiers in immunology 5: 606.PubMedPubMedCentral
19.
Zurück zum Zitat Schmittgen, T.D., and K.J. Livak. 2008. Analyzing real-time PCR data by the comparative CT method. Nature protocols 3: 1101–1108.CrossRef Schmittgen, T.D., and K.J. Livak. 2008. Analyzing real-time PCR data by the comparative CT method. Nature protocols 3: 1101–1108.CrossRef
20.
Zurück zum Zitat Ciccia, F., M. Bombardieri, A. Principato, A. Giardina, C. Tripodo, R. Porcasi, S. Peralta, V. Franco, E. Giardina, and A. Craxi. 2009. Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology 60: 955–965.CrossRef Ciccia, F., M. Bombardieri, A. Principato, A. Giardina, C. Tripodo, R. Porcasi, S. Peralta, V. Franco, E. Giardina, and A. Craxi. 2009. Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology 60: 955–965.CrossRef
21.
Zurück zum Zitat Mei, Y., F. Pan, J. Gao, R. Ge, Z. Duan, Z. Zeng, F. Liao, G. Xia, S. Wang, and S. Xu. 2011. Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis. Clinical rheumatology 30: 269–273.CrossRef Mei, Y., F. Pan, J. Gao, R. Ge, Z. Duan, Z. Zeng, F. Liao, G. Xia, S. Wang, and S. Xu. 2011. Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis. Clinical rheumatology 30: 269–273.CrossRef
22.
Zurück zum Zitat Appel, H., R. Maier, J. Bleil, A. Hempfing, C. Loddenkemper, U. Schlichting, U. Syrbe, and J. Sieper. 2013. In situ analysis of interleukin–23–and interleukin-12–positive cells in the spine of patients with ankylosing spondylitis. Arthritis & Rheumatism 65: 1522–1529.CrossRef Appel, H., R. Maier, J. Bleil, A. Hempfing, C. Loddenkemper, U. Schlichting, U. Syrbe, and J. Sieper. 2013. In situ analysis of interleukin–23–and interleukin-12–positive cells in the spine of patients with ankylosing spondylitis. Arthritis & Rheumatism 65: 1522–1529.CrossRef
23.
Zurück zum Zitat DeLay, M.L., M.J. Turner, E.I. Klenk, J.A. Smith, D.P. Sowders, and R.A. Colbert. 2009. HLA–B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis & Rheumatism 60: 2633–2643.CrossRef DeLay, M.L., M.J. Turner, E.I. Klenk, J.A. Smith, D.P. Sowders, and R.A. Colbert. 2009. HLA–B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis & Rheumatism 60: 2633–2643.CrossRef
24.
Zurück zum Zitat Cauli, A., G. Dessole, M. Fiorillo, A. Vacca, A. Mameli, P. Bitti, G. Passiu, R. Sorrentino, and A. Mathieu. 2002. Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: A possible further susceptibility factor for the development of disease. Rheumatology 41: 1375–1379.CrossRef Cauli, A., G. Dessole, M. Fiorillo, A. Vacca, A. Mameli, P. Bitti, G. Passiu, R. Sorrentino, and A. Mathieu. 2002. Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: A possible further susceptibility factor for the development of disease. Rheumatology 41: 1375–1379.CrossRef
25.
Zurück zum Zitat Liu, S.-Q., H.-C. Yu, Y.-Z. Gong, and N.-S. Lai. 2006. Quantitative measurement of HLA-B27 mRNA in patients with ankylosing spondylitis–correlation with clinical activity. The Journal of rheumatology 33: 1128–1132.PubMed Liu, S.-Q., H.-C. Yu, Y.-Z. Gong, and N.-S. Lai. 2006. Quantitative measurement of HLA-B27 mRNA in patients with ankylosing spondylitis–correlation with clinical activity. The Journal of rheumatology 33: 1128–1132.PubMed
26.
Zurück zum Zitat Colbert, R.A., T.M. Tran, and G. Layh-Schmitt. 2014. HLA-B27 misfolding and ankylosing spondylitis. Molecular Immunology 57: 44–51.CrossRef Colbert, R.A., T.M. Tran, and G. Layh-Schmitt. 2014. HLA-B27 misfolding and ankylosing spondylitis. Molecular Immunology 57: 44–51.CrossRef
27.
Zurück zum Zitat Feng, Y., J. Ding, C.M. Fan, and P. Zhu. 2012. Interferon-γ contributes to HLA-B27-associated unfolded protein response in spondyloarthropathies. The Journal of rheumatology 39: 574–582.CrossRef Feng, Y., J. Ding, C.M. Fan, and P. Zhu. 2012. Interferon-γ contributes to HLA-B27-associated unfolded protein response in spondyloarthropathies. The Journal of rheumatology 39: 574–582.CrossRef
28.
Zurück zum Zitat Gu, J., M. Rihl, E. Märker-Hermann, D. Baeten, J.G. Kuipers, Y.W. Song, W.P. Maksymowych, R. Burgos-Vargas, E.M. Veys, and F. De Keyser. 2002. Clues to pathogenesis of spondyloarthropathy derived from synovial fluid mononuclear cell gene expression profiles. The Journal of Rheumatology 29: 2159–2164.PubMed Gu, J., M. Rihl, E. Märker-Hermann, D. Baeten, J.G. Kuipers, Y.W. Song, W.P. Maksymowych, R. Burgos-Vargas, E.M. Veys, and F. De Keyser. 2002. Clues to pathogenesis of spondyloarthropathy derived from synovial fluid mononuclear cell gene expression profiles. The Journal of Rheumatology 29: 2159–2164.PubMed
29.
Zurück zum Zitat Ciccia, F., A. Accardo-Palumbo, A. Rizzo, G. Guggino, S. Raimondo, A. Giardina, A. Cannizzaro, R.A. Colbert, R. Alessandro, and G. Triolo. 2014. Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation. Annals of the rheumatic diseases 73: 1566–1574.CrossRef Ciccia, F., A. Accardo-Palumbo, A. Rizzo, G. Guggino, S. Raimondo, A. Giardina, A. Cannizzaro, R.A. Colbert, R. Alessandro, and G. Triolo. 2014. Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation. Annals of the rheumatic diseases 73: 1566–1574.CrossRef
30.
Zurück zum Zitat DeLay, M.L., M.J. Turner, E.I. Klenk, J.A. Smith, D.P. Sowders, and R.A. Colbert. 2009. HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis & Rheumatism 60: 2633–2643.CrossRef DeLay, M.L., M.J. Turner, E.I. Klenk, J.A. Smith, D.P. Sowders, and R.A. Colbert. 2009. HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis & Rheumatism 60: 2633–2643.CrossRef
31.
Zurück zum Zitat Rahman, P., R.D. Inman, D.D. Gladman, J.P. Reeve, L. Peddle, and W.P. Maksymowych. 2008. Association of interleukin-23 receptor variants with ankylosing spondylitis. Arthritis & Rheumatism 58: 1020–1025.CrossRef Rahman, P., R.D. Inman, D.D. Gladman, J.P. Reeve, L. Peddle, and W.P. Maksymowych. 2008. Association of interleukin-23 receptor variants with ankylosing spondylitis. Arthritis & Rheumatism 58: 1020–1025.CrossRef
32.
Zurück zum Zitat Reveille, J.D., A.-M. Sims, P. Danoy, D.M. Evans, P. Leo, J.J. Pointon, R. Jin, X. Zhou, L.A. Bradbury, and L.H. Appleton. 2010. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nature genetics 42: 123.CrossRef Reveille, J.D., A.-M. Sims, P. Danoy, D.M. Evans, P. Leo, J.J. Pointon, R. Jin, X. Zhou, L.A. Bradbury, and L.H. Appleton. 2010. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nature genetics 42: 123.CrossRef
33.
Zurück zum Zitat Goodall, J.C., C. Wu, Y. Zhang, L. McNeill, L. Ellis, V. Saudek, and J.H. Gaston. 2010. Endoplasmic reticulum stress-induced transcription factor, CHOP, is crucial for dendritic cell IL-23 expression. Proceedings of the national academy of Sciences 107: 17698–17703.CrossRef Goodall, J.C., C. Wu, Y. Zhang, L. McNeill, L. Ellis, V. Saudek, and J.H. Gaston. 2010. Endoplasmic reticulum stress-induced transcription factor, CHOP, is crucial for dendritic cell IL-23 expression. Proceedings of the national academy of Sciences 107: 17698–17703.CrossRef
34.
Zurück zum Zitat Turner, M.J., D.P. Sowders, M.L. DeLay, R. Mohapatra, S. Bai, J.A. Smith, J.R. Brandewie, J.D. Taurog, and R.A. Colbert. 2005. HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein response. The Journal of Immunology 175: 2438–2448.CrossRef Turner, M.J., D.P. Sowders, M.L. DeLay, R. Mohapatra, S. Bai, J.A. Smith, J.R. Brandewie, J.D. Taurog, and R.A. Colbert. 2005. HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein response. The Journal of Immunology 175: 2438–2448.CrossRef
35.
Zurück zum Zitat de Castro, C.P., S.A. Jones, C.N. Cheallaigh, C.A. Hearnden, L. Williams, J. Winter, E.C. Lavelle, K.H. Mills, and J. Harris. 2012. Autophagy regulates IL-23 secretion and innate T cell responses through effects on IL-1 secretion. The Journal of Immunology 189: 4144–4153.CrossRef de Castro, C.P., S.A. Jones, C.N. Cheallaigh, C.A. Hearnden, L. Williams, J. Winter, E.C. Lavelle, K.H. Mills, and J. Harris. 2012. Autophagy regulates IL-23 secretion and innate T cell responses through effects on IL-1 secretion. The Journal of Immunology 189: 4144–4153.CrossRef
36.
Zurück zum Zitat Chicote, J., V.J. Yuste, J. Boix, and J. Ribas. 2020. Cell death triggered by the autophagy inhibitory drug 3-methyladenine in growing conditions proceeds with DNA damage. Frontiers in Pharmacology 11: 580343. Chicote, J., V.J. Yuste, J. Boix, and J. Ribas. 2020. Cell death triggered by the autophagy inhibitory drug 3-methyladenine in growing conditions proceeds with DNA damage. Frontiers in Pharmacology 11: 580343.
37.
Zurück zum Zitat Siebert, S., N.L. Millar, and I.B. McInnes. 2019. Why did IL-23p19 inhibition fail in AS: A tale of tissues, trials or translation? Annals of the Rheumatic Diseases 78: 1015–1018.CrossRef Siebert, S., N.L. Millar, and I.B. McInnes. 2019. Why did IL-23p19 inhibition fail in AS: A tale of tissues, trials or translation? Annals of the Rheumatic Diseases 78: 1015–1018.CrossRef
38.
Zurück zum Zitat Baeten, D., M. Østergaard, J.C. Wei, J. Sieper, P. Järvinen, L.S. Tam, C. Salvarani, T.H. Kim, A. Solinger, Y. Datsenko, et al. 2018. Risankizumab, an IL-23 inhibitor for ankylosing spondylitis: Results of a randomised double-blind placebo-controlled proof-of-concept dose-finding phase 2 study. Annals of the Rheumatic Diseases 77: 1295–1302.CrossRef Baeten, D., M. Østergaard, J.C. Wei, J. Sieper, P. Järvinen, L.S. Tam, C. Salvarani, T.H. Kim, A. Solinger, Y. Datsenko, et al. 2018. Risankizumab, an IL-23 inhibitor for ankylosing spondylitis: Results of a randomised double-blind placebo-controlled proof-of-concept dose-finding phase 2 study. Annals of the Rheumatic Diseases 77: 1295–1302.CrossRef
Metadaten
Titel
Upregulation of Unfolded Protein Response and ER Stress–Related IL-23 Production in M1 Macrophages from Ankylosing Spondylitis Patients
verfasst von
Alireza Rezaiemanesh
Mahdi Mahmoudi
Ali Akbar Amirzargar
Mahdi Vojdanian
Farhad Babaie
Jila Mahdavi
Misagh Rajabinejad
Ahmad Reza Jamshidi
Mohammad Hossein Nicknam
Publikationsdatum
03.02.2022
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 2/2022
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-021-01575-z

Weitere Artikel der Ausgabe 2/2022

Inflammation 2/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.